Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

76 healthy * heterosexual

12th World AIDS Conference

SKeyword Abstract --
aking truckers safe and lovers/Making truckers safe and 43272
ormalities in otherwise adult HIV-1 infected individuals/C 60648
provider (HIP)/Uganda healtnet project - a health information prov 34375
e antiretroviral therapy ( HEART )/Adherence to proteinase inhibitor 12298
ediatric HIV-1 disease/ Heart, lung, and immune abnormalities an 12171
ased on instantaneous heart rate histogram in HIV positive individ 12112
center during the era of /Changes in HIV/AIDS patterns of ca 442*/42430
phic study/Patterns of disease in HIV infected patients with 60995
ntification of virus load/ Heat-denatured p24 antigen testing comp 32442
the level of infection as heat-killed organisms mediate significantl 21145
ation of HIV-1 infection/ Heat shock modulation of HIV-1 infection/ 11129
ntervening to address " heat of the moment" thinking that leads to u 43295
inhibitor use in patients heavily pretreated with reverse transcripta 12340
6n" Teaching Hospital ( HEEP )/HIV infection study on patients at t 43153
our amongst groups at heightened risk of STD/HIV infection/Eco 14199
developing countries?/ Helicobacter pylori: A potentially unrecog 22115
nts with antral gastritis/ pylori infection in HIV positiv 32122
patients/Prevalence of helicobacter pylori infection in HIV-infecte 32109
he Italian National AIDS Help-Line 167-861061/The Italian Nation 33299
shop: an original tool/A help-with-housing workshop: an original t 60837
training programmes/" Help the Helpers" - Promoting AIDS awar 13580
vate nursing homes: A help based programme in suburbs of Mum 12425
ve with HIV through self /Learning to live with HIV through self 14346
ity and exclusion in self organisations/Issues of conformity a 34294
ation/Groups of mutual (gam's): beginning its decentralizatio 34304
ommunity based self groups in mobilsation and prevention 60940
a/Positive Club - A self group of people with HIV in Russia/P 60960
nt anti-HIV therapy on T helper cell homeostasis and type 1 cytokin 219*/21169
requires virus-specific and CTL function and levels of CTL 598*/31130
/Comparison between T-lymphocyte counts obtained by z 42193
rogrammes/"Help the Helpers "- Promoting AIDS awareness am 13580
rivers and truck drivers/ helpers /Knowledge, attitudes and sexual 23341
rant workers (domestic ) to HIV/AIDS/Factors that contrib 23567
mbers and other natural to engage substance abusers in tr 33604
selling and testing - Is it helpful?/Client's views on HIV counselling 134*/33265
ated loss/Grief at work: Helping organizations cope with AIDS-rel 545*/24243
amily. "Mussa's story"/ children to cope with illness or dea 24298
hemselves from AIDS/ gay men in a provincial Vietnames 43334
f the self-help in mutual helping groups/The role of the self-help in 34298
ience/A global alliance school personnel address HIV/AI 44288
n efficient alternative people with AIDS to integrate and 60137
arch centre in Uganda/ Helpline telephone and face to face couns 60956
HIV and AIDS volunteer helpline training programme in response t 60663
strategies for NGOS to helps women and youth to have an effect a 14202
inhibitor support group patients increase knowledge and m 60574
mia and MAC infection/ Hematocrit, symptoms and quality of life in 60149
viral therapy (HAART)/ Hematological parameters correlate with 32139
se activity impairment in hematopoietic progenitor cells (CD34+) o 21118
ion of nef and vpu in six hemophilia B patients after clonal HIV-1 in 11146
ositive adolescents with /Sexual behavior change amo 43286
ssion of HIV infection in hemophiliacs /Hepatitis C virus (HCV) ge 13306
virus (HCV)-infection in and i.v. drug users/Effect of 32107
HIV infected Japanese hemophilic patients/Natural protease mut 60444
ation dissemination for hemophilics living with HIV in India/Using 13397
d patients/Incidence of hemorrhagic syndrome in HIV-infected pa 32157
nts with AIDS/Acquired hemostatic inhibitors (AHI) in patients with 32143
IV infection/Bartonella henselae serostatus is not correlated with 32189
HIV infection and AIDS/ Hepatic histopathology in HIV infection an 60015
d patients/Efficacy and hepatic tolerance of treatment with protea 12326
d, North India/HIV and hepatitis-B viral infections in Jailmates of 23519
tbreak of HIV infection/ Hepatitis C prevalence and incidence in V 13296
ection in hemophiliacs/ C virus (HCV) genotypes and pr 13306
e and prognostic value/ C in the EuroSIDA Cohort of Eur 22261
n of prevalence of HIV, and STDs in gate prisons of Rio 23562
nts of recent diagnosis/ C in HIV positive patients of rece 32115
ral treatment (HAART)/ B flare after highly active antiretr 60323
hort, Sao Paulo, Brazil/ C prevalence in a cohort among 60753
nteraction of HIV-1 and hepatitis B virus (HBV) in mixed infection/ 11160
Vertical transmission of C in children born to HIV-infected 12168
se inhibitors in HIV and C virus (HCV) co-infected patient 12326
sers in Europe/HIV and B/C infection among injecting dru 13192
prevalence of HIV and B and C virus among injecting dr 13224
we/The relationship of B virus and HIV seropositivity in 13301

val after HIV infection in B vaccine cohorts in Amsterdam, 13357
roconversions for HIV, B and hepatitis C among a cohort 13382
ell immune response to C virus antigens/HIV-infection al 21182
gin and granulomatous in HIV-1-infected patients/Fever 22134
of long-term HAART on C (HCV) viremia/Lack of effect o 18*/22238
ed patients with chronic C/Long-term response to interfe 20*/22242
AART/Rapidly evolving C virus infection in HIV co-infecte 17*/22243

Keyword

Abstr,

Detection of GB virus-C/ G virus (GBV-C/HGV) among ho
rotease inhibitors on C viral (HCV) load and serum ala
ation between HIV and C co-infection: A case control stu
Faso/Co-infection with B and HIV in pregnant women in
nic/Seroprevalence of C antibody and hepatitis B surfac
ence and genotypes of G virus and hepatitis C virus amo
nts/Immunogenicity of B vaccine against in HIV seropos
B treatment for chronic in the AIDS spectrum: Concomit
rsion rate of HIV and of A virus infection during an intrave
dia/Spread of HIV and viruses through the use of injecti
ant transmission of HIV, C and hepatitis G virus in women
lence and incidence of B among men who have sex with
e association of active B and C (HBV and HCV) infectio
via/Prevalence of HIV, B and C and syphilis infection in
Paulo, Brazil/Syphilis, and HIV prevalence among low i
ffect of HIV-infection on C virus (HCV)-infection in hemop
with concurrent chronic C and HIV infection: A case contr
2a treatment in chronic C (HCV) in HIV infected patients
conversion of a precore B virus mutant infection with lami
ural course of chronic C /Evaluation of HIV infection's infl: Frequency, relation to C virus and HIV-viral load/Erythe
d serology for syphilis, B and HIV among commercial se
et vaccinated against B/How to encourage youth to get
nt/The effectiveness of B vaccine in the HIV-infected pati
s/Immunisation against B in HIV positive patients/Immun
avioural risk factors for B (HBV), hepatitis C (HCV) and
users in Japan/HIV and virus infection among drug users
en 1988 and 1995/HIV, B and C among drug users in met
er two years/HIV- and B and C infection controlled in a
fection/Chronic active and liver cirrhosis are crucial co
als/Tests for STDs and may foretell the HIV seroconvers
ciency virus (HIV) and C virus (HCV) - Implications for d
/Practical outcomes of B and C virus (HBV, HCV) during
s/Polyhistidine-tagged B core particles as carriers of HI
viral therapy (HAART)/ Hepatotoxicity after introduction of highly
n the leucine zipper-like heptad repeat sequence of HIV-1 gp41 do
IV/AIDS patients using herb medicine (3G)/Control of neuropathy
WA perspective/Use of herbal and holistic therapy for treatment a
tudy/Effect of unique formulation in Indian HIV patients:
DS patients/The role of supplementation in the lives of HIV
nd safety of a new poly drug in the management of HIV infe
nts/A study on Chinese formula XQ-9302 treatment for AID
n vitro activity/Multiple therapy: A new approach into antivi
of nationwide HIV/AIDS formulary/Development of nationwi
tients Through Tibetan medicines & care/Improving the qu
d persons with Chinese herbs:A randomized, placebo-controlled t
tion amongst IDUs and heroin users from the slums/Drug detoxifi
ogic data on the role of on CD4+ decline in injecting drug u
ohort of non-injecting users/Transitions to injecting and s
tices/Viability of HIV in preparation: A two-city comparison
n a medically controlled prescription program/Reduction of
I Tanzania/Antibody to Herpes simplex virus type 2 as a marker of
edictor of HIV infection/ zoster as a predictor of HIV infectio
d clinical expression of herpes simplex virus infections among wo
e of HIV/Acquisition of simplex type 2 (HSV-2) infection in
e of infection by human virus type 8 in the US and Africa/C
/Cytomegalovirus and simplex virus are not associated wi
net/Acyclovir-resistant zoster in 18 HIV-infected patients:
nces rectal infection by simplex virus in mice/Nonoxynol-9
h HIV infection/Human herpesvirus-8 seroprevalence in children
or acquisition of human herpesvirus 8 infection/A population-bas
V Study: WIHS/Human 8 (HHV8) infection of periphe
pidemiology of human 8 (HHV-8) among clients atte
mary infection of human 6 in children with perinatal HI
f six clinically important genomes/A multiplex nested
endogenous retrovirus HERV-K /A Rev/RRE-like mechanism regu
The case of Bosnia and Herzegovina "/"Implications of complex e 2
The case of Bosnia and /Implications of HIV/AIDS pe
The case of Bosnia and /Surveillance of HIV/AIDS an
V-1 in Tanzania: Use of heteroduplex mobility assay (HMA) for HI
subtypes in Senegal by mobility assay (HMA)/Char
networks of drug users/ Heterogeneity of risk: Variability in social
opriate delineation of a heterogenous target population into homo
y and efficacy following heterologous challenge/Attenuated SIVv f
ted to homophobia and heterosexism in health care settings/Self
ogy of HIV-1 in Taiwan: Heterosexual males with HIV-1 E had sign
acterial vaginosis (BV)/ and perinatal transmission 5
ndary epidemic among heterosexual women in Europe/The male
exual risk behavior in HIV-discordant couples/Aw
Interventions to reduce HIV risk for women: Current

act
22250
22252
19*/22255
22259
22263
22264
22327
23146
23211
23243
23293
23367
23378
23379
23554
32107
32114
32116
32118
32120
32268
33248
33567
42405
42418
43411
60087
60440
60493
60675
60737
60738
60806
60824
12288
11121
60259
22487
42385
42392
42394
60010
60205
60381
60781
42381
12413
13334
13382
23196
43302
14117
42127
22191
23363
31189
32135
32269
33143
31191
13295
31196
31197
31201
41151
11208
244*/14139
44236
60910
13110
13112
23177
33373

546*/11238
60743
13148
i27*/23347
13200
14146
14270